highperformr logo

Althea's Overview

Total employees1618
HeadquartersMelbourne
Founded2014

Althea Group Holdings Ltd (ASX:AGH) is an Australian-headquartered global pharmaceutical company dedicated to the research, development, manufacturing, and distribution of cannabis-based medicines and related products. Operating across regulated markets in Australia, Europe (UK, Germany), and North America (Canada), Althea aims to improve patient health outcomes through innovative and high-quality medicinal cannabis solutions.

Where is Althea's Headquarters?

HQ Function

Serves as the central hub for Althea Group's global strategy, corporate governance, financial management, investor relations, and oversight of research, development, and commercial operations worldwide.

Notable Features:

Located within 101 Collins Street, a landmark premium-grade office tower in Melbourne's CBD, known for its prestigious address and high-quality amenities.

Work Culture:

Professional, innovative, and compliance-focused, reflecting its position in the pharmaceutical and healthcare sector. Emphasizes collaboration, research-driven decision-making, and adherence to stringent regulatory standards.

HQ Significance:

Key to coordinating Althea's international operations, managing partnerships, and driving the company's growth strategy in the evolving global medicinal cannabis market.

Values Reflected in HQ: The choice of a premium, centrally-located headquarters reflects Althea's commitment to professionalism, quality, global connectivity, and ambition within the pharmaceutical industry.

Location:

Althea Group supports its global operations through key functions including research and development, licensed manufacturing (notably via its Peak Processing Solutions facility in Canada and contract manufacturers), sales, marketing, and distribution of medicinal cannabis products. The company has established commercial operations and patient access programs in Australia, the United Kingdom, Germany, and Canada, and supplies products to other European markets, leveraging local expertise and regulatory frameworks.

Street Address:

Suite 2, Level 27, 101 Collins Street

City:

Melbourne

State/Province:

VIC

Country:

Australia

Althea's Global Presence

Tecumseh, Ontario, Canada

Address: Peak Processing Solutions, 2655 County Rd 42, Tecumseh, Ontario, N0R 1L0, Canada

Serves as Althea's primary North American manufacturing hub, crucial for product development, quality control, and supply to the Canadian recreational and global medicinal markets.

London, England, United Kingdom

Address: Althea MMJ UK Ltd, Salisbury House, London Wall, London, EC2M 5PS, United Kingdom

Key entity for accessing and expanding within the growing UK medicinal cannabis market, navigating local regulations, and building brand presence.

Gelsenkirchen, North Rhine-Westphalia, Germany

Address: Althea Deutschland GmbH, c/o CFO AG, Munscheidstraße 14, 45886 Gelsenkirchen, Germany

Facilitates market entry and growth in Germany, one of Europe's largest and most important medicinal cannabis markets, ensuring compliance and supply chain integrity.

Buying Intent Signals for Althea

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Althea

As of April 2025, Althea' leadership includes:

Joshua Fegan - CEO & Managing Director
Constantinos Vafiadis - Chief Financial Officer
Stuart Linton - Chief Commercial Officer (Canada & International)
Mark Ades - Chief Commercial Officer (Australia & APAC)
Gino Coolegem - Chief Commercial Officer (Europe)

Investors of Althea

Althea has been backed by several prominent investors over the years, including:

HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED
BNP PARIBAS NOMINEES PTY LTD
CITICORP NOMINEES PTY LIMITED
MERRILL LYNCH (AUSTRALIA) NOMINEES PTY LIMITED

Executive New Hires/Exits in the Last 12 Months

Hire3
Exits1

Althea Group has strategically bolstered its leadership over the past 12-18 months, appointing a new Chief Financial Officer, a Chief Commercial Officer for Europe, and a new Company Secretary, signaling a focus on financial stewardship, European market expansion, and corporate governance.

Departures

Catherine Davies, Catherine Davies resigned as Company Secretary.

New Appointments:

Gino Coolegem, Gino Coolegem appointed to lead European commercial strategy and drive growth in key markets.
Michael Fegan, Michael Fegan appointed as Company Secretary.
Constantinos Vafiadis, Constantinos Vafiadis appointed as Chief Financial Officer.

Technology (Tech Stack) used by Althea

Discover the tools Althea uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Althea Email Formats and Examples

Althea Group primarily utilizes the email domain '@althea.life' for its corporate communications, including for its executive team. The most commonly observed and verified format is [first_initial].[last_name]. For general inquiries, '@altheagroupholdings.com' is also used.

[first_initial].[last_name]@althea.life

Format

j.fegan@althea.life

Example

85%

Success rate

News and media

Proactive InvestorsMay 21, 2024

Althea Group Holdings secures $2.2M funding boost

Althea Group Holdings Ltd has successfully raised A$2.2 million through a strategic placement and a share purchase plan, aiming to accelerate sales growth and achieve positive cash flow....more

Proactive InvestorsMay 20, 2024

Althea Group Holdings appoints Gino Coolegem as Chief Commercial Officer, Europe to drive growth

Althea has appointed Gino Coolegem as its Chief Commercial Officer for Europe to spearhead commercial strategy and expansion in key European medicinal cannabis markets....more

Small CapsFebruary 28, 2024

Althea Group Holdings reports record UK revenue as patient numbers surge

Althea Group announced record revenue from its UK operations, driven by a significant increase in patient numbers for its medicinal cannabis products....more

ASX AnnouncementNovember 1, 2023

Althea Group Holdings Company Secretary Appointment/Resignation

Althea Group Holdings announced the resignation of Ms Catherine Davies as Company Secretary and the appointment of Mr Michael Fegan as Company Secretary, effective 1 November 2023....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Althea, are just a search away.